Generation of control human iPSC line INSTEMi001-A from PBMCs of a healthy Indian donor

Generation of control human iPSC line INSTEMi001-A from PBMCs of a healthy Indian donor

Human pluripotent stem cells serve as a robust model system to study disease pathogenesis in a dish and search for various targeted therapeutics. Collection of control lines from healthy individuals are essential for any study. Therefore, we have generated hiPSC line from a healthy male donor after...

Full description

Bibliographic Details
Main Authors:	Niharika Patlolla, Pretty Ponnachan, Colin Jamora, Deepti Abbey
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506123000983

Similar Items

Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi050-A from a healthy donor
by: Xiaomeng Yang, et al.
Published: (2024-02-01)

Generation of three human iPSC lines from patients with Huntington’s disease with different CAG lengths and human control iPSC line from a healthy donor
by: Ewelina Latoszek, et al.
Published: (2022-10-01)

Generation of two isogenic iPSC lines from a healthy male donor of European ancestry
by: S. Edwards, et al.
Published: (2024-06-01)

Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors
by: Katerina Vlahos, et al.
Published: (2023-06-01)

Generation of iPSC line (FMCPGHi003-A) from human PBMCs of a patient with Familial hemiplegic migraine type 3
by: Tao Wang, et al.
Published: (2024-09-01)

Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy
by: N.M. Daya, et al.
Published: (2023-10-01)

Establishment of two iPSC lines from healthy donor with heterozygous mutation in the SLC26A4 gene
by: SiJun Li, et al.
Published: (2022-10-01)

Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family
by: Janette Tong, et al.
Published: (2019-01-01)

Generation of an iPSC line (SDQLCHi030-A) derived from PBMCs of a patient with Lesch-Nyhan syndrome caused by HPRT1 mutation
by: Yue Li, et al.
Published: (2024-02-01)

Pro-maturational effects of human iPSC-derived cortical astrocytes upon iPSC-derived cortical neurons
by: Anne Hedegaard, et al.
Published: (2020)

Generation of two human iPSC lines from dermal fibroblasts of adult- and juvenile-onset Huntington's disease patients and two healthy donors
by: Marta Piechota, et al.
Published: (2023-09-01)

In vitro Differentiation of Human iPSC-derived Cardiovascular Progenitor Cells (iPSC-CVPCs)
by: Agnieszka D’Antonio-Chronowska, et al.
Published: (2020-09-01)

Generation of an integration-free iPSC line (CSCRi005-A) from erythroid progenitor cells of a healthy Indian male individual
by: Kannan V. Manian, et al.
Published: (2018-05-01)

Generation of two TMEM16A knockout iPSC clones each from a healthy human iPSC line, from a Cystic Fibrosis patient specific line with p.Phe508del mutation and from the gene corrected iPSC line
by: Mark-Christian Jaboreck, et al.
Published: (2022-10-01)

In vitro Differentiation of Human iPSC-derived Retinal Pigment Epithelium Cells (iPSC-RPE)
by: Agnieszka D’Antonio-Chronowska, et al.
Published: (2019-12-01)

Generation of an iPSC line (TSHSUi001-A) from a patient with Peutz-Jeghers syndrome due to STK11 mutation
by: Teng Wang, et al.
Published: (2023-09-01)

Maturing iPSC-Derived Cardiomyocytes
by: Bor Luen Tang
Published: (2020-01-01)

Generation of two iPSC lines (MHHi001-A-12 and MHHi001-A-13) carrying biallelic truncating mutations at the 3′-end of SRCAP using CRISPR/Cas9
by: J. Rhode, et al.
Published: (2023-12-01)

Modeling riboflavin transporter deficiency type 2: from iPSC-derived motoneurons to iPSC-derived astrocytes
by: Valentina Magliocca, et al.
Published: (2024-07-01)

Establishment of an iPSC line (BCHNDi001-A) from a patient with nicotinamide nucleotide repair system deficiency caused by biallelic NAXD mutations
by: Chaolong Xu, et al.
Published: (2024-04-01)

Generation of a homozygous CRYAB p.Arg120Gly mutant (UKEi001-A-1) from a human iPSC line
by: Niels Pietsch, et al.
Published: (2023-09-01)

The utilisation of hydrogels for iPSC-cardiomyocyte research
by: Patel, L, et al.
Published: (2023)

Safety of GMP-compliant iPSC lines generated by Sendai virus transduction is dependent upon clone identity and sex of the donor
by: Zuzanna Kuczynska, et al.
Published: (2024-03-01)

Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi051-A from an autism spectrum disorder patient with compound CHD8 gene mutations
by: Yuxuan Fan, et al.
Published: (2023-06-01)

Generation of a homozygous TIGIT gene knockout (TIGIT−/−) human iPSC line (MUSIi001-A-3) using CRISPR/Cas9 system
by: Jakkrapatra Srisantitham, et al.
Published: (2024-12-01)

Generation of a human iPSC line BCHNCi001-A from a patient with uridine-responsive epileptic encephalopathy carrying biallelic CAD mutations
by: Ling Zhou, et al.
Published: (2022-12-01)

Generation of a human induced pluripotent stem cell (iPSC, DVSi001-A) with a heterozygous mutation in KRAS (A209T)
by: Xu Wang, et al.
Published: (2024-10-01)

Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the PSEN1 H163R mutation
by: Damián Hernández, et al.
Published: (2024-09-01)

Generation of a human Tropomyosin 1 knockout iPSC line
by: Madison B. Wilken, et al.
Published: (2023-09-01)

Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi055-A from a patient with NEDSDV carrying a heterozygote mutation in the CTNNB1 gene
by: Yanan Yang, et al.
Published: (2024-04-01)

Generation of a human iPSC cell line (MUSIi017-A) from a donor with O negative blood type
by: Nittaya Jiamvoraphong, et al.
Published: (2024-08-01)

Generation of human iPSC-derived cerebellar organoids
by: Tolonen, J-P, et al.
Published: (2024)

iPSC-derived cells for whole liver bioengineering
by: Kayque Alves Telles-Silva, et al.
Published: (2024-02-01)

Engineering considerations of iPSC-based personalized medicine
by: Sangbae Park, et al.
Published: (2023-07-01)

Generation of a human induced pluripotent stem cell line (SHUPLi002-A) from PBMCs of a healthy female donor
by: Beixu Li, et al.
Published: (2024-06-01)

Generation of Human Induced Pluripotent Stem Cell line from PBMCs of Healthy Donors using Integration-free Sendai virus Technology
by: Swati Chitrangi, et al.
Published: (2023-06-01)

The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model
by: Valery Zayat, et al.
Published: (2023-01-01)

Development of a human iPSC-derived placental barrier-on-chip model
by: Agathe Lermant, et al.
Published: (2023-07-01)

iPSCs and iPSC-derived cells as a model of human genetic and epigenetic variation
by: Kara Quaid, et al.
Published: (2025-02-01)

Generation of human iPSC-derived 3D bile duct within liver organoid by incorporating human iPSC-derived blood vessel
by: Erica Carolina, et al.
Published: (2024-08-01)